There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oncolytics Biotech (ONCY – Research Report), Stealth Biotherapeutics (MITO – Research Report) and Genocea Biosciences (GNCA – Research Report) with bullish sentiments. Oncolytics Biotech (ONCY) In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Oncolytics Biotech, with a price target of $15.00. The company's shares closed last Friday at $1.55, close to its 52-week low of $1.25. According to TipRanks.com, Trucchio has 0 stars on 0-5 stars ranking scale with an average return of -21.2% and a 27.3% success rate.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oncolytics-biotech-oncy-stealth-biotherapeutics-mito-and-genocea-biosciences-gnca?utm_source=advfn.com&utm_medium=referral